Evidence map›Paper›PMID 37653076›Full record

ArticleClinical oral investigations2023

Piranha-etched titanium nanostructure reduces biofilm formation in vitro.

Khaled Mukaddam, Monika Astasov-Frauenhoffer, Elizaveta Fasler-Kan, Sabrina Ruggiero, Farah Alhawasli, Marcin Kisiel, Ernst Meyer, Jochen Köser, Michael M Bornstein, Raphael S Wagner and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical oral investigations, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Khaled MukaddamDepartment of Oral Surgery, University Center for Dental Medicine Basel (UZB), University of Basel, Mattenstrasse 40, 4058, Basel, Switzerland. khaled.mukaddam@unibas.ch.
Monika Astasov-FrauenhofferDepartment Research, University Center for Dental Medicine Basel (UZB), University of Basel, Mattenstrasse 40, 4058, Basel, Switzerland.
Elizaveta Fasler-KanDepartment of Pediatric Surgery, Children's Hospital, Inselspital Bern, University of Bern and Department of Biomedical Research, University of Bern, Freiburgstrasse 15, 3010, Bern, Switzerland.
Sabrina RuggieroDepartment of Pediatric Surgery, Children's Hospital, Inselspital Bern, University of Bern and Department of Biomedical Research, University of Bern, Freiburgstrasse 15, 3010, Bern, Switzerland.
Farah AlhawasliDepartment of Biomedicine University of Basel and University Hospital Basel, Hebelstrasse 20, 4031, Basel, Switzerland.
Marcin KisielDepartment of Physics, University of Basel, Klingelbergstraße 82, 4056, Basel, Switzerland.
Ernst MeyerDepartment of Physics, University of Basel, Klingelbergstraße 82, 4056, Basel, Switzerland.
Jochen KöserInstitut für Chemie und Bioanalytik, Hochschule für Life Sciences, Hofackerstrasse 30, 4132, Muttenz, Switzerland.
Michael M BornsteinDepartment of Oral Health & Medicine, University Center for Dental Medicine Basel (UZB), University of Basel, Mattenstrasse 40, 4058, Basel, Switzerland.
Raphael S WagnerInstitut Straumann AG, Peter-Merian-Weg 12, 4052, Basel, Switzerland.
Sebastian KühlDepartment of Oral Surgery, University Center for Dental Medicine Basel (UZB), University of Basel, Mattenstrasse 40, 4058, Basel, Switzerland.
University of Basel · CHUniversity Hospital of Bern · CHStraumann (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesNano-modified surfaces for dental implants may improve gingival fibroblast adhesion and antibacterial characteristics through cell-surface interactions. The present study investigated how a nanocavity titanium surface impacts the viability and adhesion of human gingival fibroblasts (HGF-1) and compared its response to Porphyromonas gingivalis with those of marketed implant surfaces. MATERIAL AND

methodsCommercial titanium and zirconia disks, namely, sandblasted and acid-etched titanium (SLA), sandblasted and acid-etched zirconia (ZLA), polished titanium (PT) and polished zirconia (ZrP), and nanostructured disks (NTDs) were tested. Polished titanium disks were etched with a 1:1 combination of 98% H

resultsEtching created nanocavities with 10-20-nm edge-to-edge diameters. Chemical etching increased the average surface roughness and decreased the surface adherence, while polishing and flattening of ZrP increased adhesion. However, only the NTDs inhibited biofilm formation and bacterial adherence. The NTDs showed antibacterial effects and P. gingivalis vitality reductions. The HGF-1 cells demonstrated greater viability on the NTDs compared to the controls.

conclusionNanocavities with 10-20-nm edge-to-edge diameters on titanium disks hindered P. gingivalis adhesion and supported the adhesion of gingival fibroblasts when compared to the surfaces of currently marketed titanium or zirconia dental implants. CLINICAL RELEVANCE: This study prepared an effective antibacterial nanoporous surface, assessed its effects against oral pathogens, and demonstrated that surface characteristics on a nanoscale level influenced oral pathogens and gingival fibroblasts. CLINICAL

trial registrationnot applicable.

Indexed as

Dental ImplantsNanostructuresAnti-Bacterial AgentsBiofilmsFibroblastsHumansHydrogen PeroxideSurface PropertiesTitaniumZirconiumAnti-Bacterial AgentsDental ImplantsHydrogen PeroxideTitaniumZirconiumzirconium oxideAntibacterialImplant dentistryNanostructurePeri-implantitisPiranha etchingSurface

Identifiers

PMID37653076
PMCPMC10560173
OpenAlexW4386317572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.